PerpEquities

Abbott Laboratories (ABT) balance sheet

NYSE · Healthcare · Medical - Devices · 115,000 employees · CEO Robert Ford

Price
$106.20 +1.56%
Market cap
$184B
Enterprise value
$211B
Last report
Q3 '26 filed 2026-09-30
Next report
2027-01-28 EPS est. $1.64

At the end of Q2 '26 Abbott Laboratories (ABT) held $5.6B in cash and short-term investments against $32.6B of debt incl. leases. Total assets $109B, total liabilities $57.5B, shareholders' equity $51.1B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$6.71B$6.9B$6.28B$6.99B$7.56B$7.62B$6.53B$6.95B$7.51B$8.52B$6.8B$5.1B
Short-term investments$338M$383M$367M$232M$230M$351M$312M$331M$222M$417M$492M$499M
Receivables$6.5B$6.57B$6.61B$6.85B$7.05B$6.93B$7.33B$7.97B$8.14B$7.93B$8.21B$8.6B
Inventory$6.65B$6.57B$6.83B$6.81B$6.81B$6.19B$6.64B$6.95B$6.71B$6.49B$6.99B$7.32B
Other current assets$2.47B$2.26B$2.29B$2.23B$2.15B$2.57B$2.34B$2.26B$2.26B$2.64B$3.01B$3B
Current assets$22.7B$22.7B$22.4B$23.1B$23.8B$23.7B$23.2B$24.5B$24.8B$26B$25.5B$24.5B
Property, plant & equipment (net)$9.55B$11.3B$10.1B$10.2B$10.6B$11.7B$10.9B$11.4B$11.5B$12.9B$12.4B$12.8B
Long-term investments$788M$799M$818M$877M$912M$886M$907M$958M$951M$918M$1.09B$1.11B
Goodwill$23.3B$23.7B$23.4B$23.3B$23.7B$23.1B$23.4B$24B$24B$24B$35.2B$35.2B
Intangible assets$9.28B$8.82B$8.3B$7.83B$7.35B$6.65B$6.26B$5.92B$5.6B$5.53B$17.9B$17.2B
Other non-current assets$6.53B$5.98B$7.49B$7.65B$8.01B$15.4B$16.8B$17.3B$17.3B$17.3B$18.4B$18.3B
Non-current assets$49.4B$50.5B$50.1B$49.9B$50.6B$57.8B$58.3B$59.5B$59.3B$60.7B$84.9B$84.7B
Total assets$72.1B$73.2B$72.5B$73B$74.4B$81.4B$81.4B$84B$84.2B$86.7B$110B$109B
Liabilities
Accounts payable$3.96B$4.3B$4.18B$4.13B$4.03B$4.2B$4.21B$4.31B$4.12B$4.24B$4.68B$4.79B
Accrued expenses$1.48B$1.6B$1.09B$1.39B$1.62B$1.7B$1.17B$1.55B$1.74B$1.75B$7.59B$8.51B
Short-term debt$1.05B$1.33B$2.01B$1.62B$2.15B$1.75B$506M$507M$1.35B$3.31B$4.41B$3.01B
Taxes payable$318M$492M$562M$601M$713M$594M$485M$390M$469M$569M$598M$411M
Other current liabilities$6.23B$6.13B$6.18B$6.03B$6.38B$5.91B$6.63B$6.69B$6.91B$5.54B$0$0
Current liabilities$13B$13.8B$14B$13.8B$14.9B$14.2B$13B$13.4B$14.6B$16.5B$18.4B$17.8B
Long-term debt$14.5B$13.6B$12.6B$13.1B$12.8B$12.6B$12.7B$12.9B$11.6B$10.8B$29.6B$29.6B
Lease obligations (non-current)$0$949M$0$0$0$896M$0$0$0$931M$0$0
Deferred tax liabilities$0$1.22B$0$0$0$1.37B$0$0$0$1.96B$0$0
Other non-current liabilities$6.88B$4.78B$6.83B$6.56B$6.6B$4.46B$6.64B$6.8B$6.74B$3.73B$9.71B$10B
Non-current liabilities$21.4B$20.5B$19.4B$19.7B$19.4B$19.4B$19.4B$19.7B$18.3B$17.4B$39.4B$39.6B
Total liabilities$34.4B$34.4B$33.4B$33.5B$34.3B$33.5B$32.4B$33.2B$32.9B$33.9B$57.7B$57.5B
Equity
Common stock & paid-in capital$24.7B$24.9B$24.7B$24.9B$25B$25.2B$25.1B$25.3B$25.4B$25.5B$25.4B$25.5B
Retained earnings$36.9B$37.6B$38B$38.4B$39.1B$47.3B$47.7B$48.5B$49.1B$49.8B$50B$49.8B
Accumulated other comprehensive income-$8.48B-$7.84B-$8.17B-$8.14B-$7.8B-$7.91B-$7.42B-$6.58B-$6.68B-$6B-$6.31B-$6.21B
Shareholders' equity$37.5B$38.6B$38.8B$39.3B$39.8B$47.7B$48.8B$50.6B$51B$52.1B$52.1B$51.1B
Debt
Total debt (incl. leases)$15.5B$15.9B$14.6B$14.8B$15B$15.3B$13.2B$13.4B$12.9B$15.1B$34B$32.6B
Net debt (debt - cash)$8.82B$8.98B$8.3B$7.77B$7.42B$7.66B$6.71B$6.49B$5.43B$6.55B$27.2B$27.5B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30

Data as of 2026-11-01